Karlström A R, Levine R L
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5552-6. doi: 10.1073/pnas.88.13.5552.
The protease of the human immunodeficiency virus is essential for replication of the virus, and the enzyme is therefore an attractive target for antiviral action. We have found that the viral protease is inhibited by approximately stoichiometric concentrations of copper or mercury ions. Inactivation by Cu2+ was rapid and not reversed by subsequent exposure to EDTA or dithiothreitol. Direct inhibition by Cu2+ required the presence of cysteine residue(s) in the protease. Thus, a synthetic protease lacking cysteine residues was not inhibited by exposure to copper. However, addition of dithiothreitol as an exogenous thiol rendered even the synthetic protease susceptible to inactivation by copper. Oxygen was not required for inactivation of either the wild-type or the synthetic protease. These results provide the basis for the design of novel types of protease inhibitors.
人类免疫缺陷病毒的蛋白酶对于病毒复制至关重要,因此该酶是抗病毒作用的一个有吸引力的靶点。我们发现,病毒蛋白酶会被大约化学计量浓度的铜离子或汞离子抑制。Cu2+导致的失活迅速,且后续暴露于EDTA或二硫苏糖醇不能使其恢复活性。Cu2+的直接抑制作用要求蛋白酶中存在半胱氨酸残基。因此,缺乏半胱氨酸残基的合成蛋白酶不会因暴露于铜而被抑制。然而,添加二硫苏糖醇作为外源性硫醇,即使是合成蛋白酶也会变得易于被铜失活。野生型或合成蛋白酶的失活都不需要氧气。这些结果为新型蛋白酶抑制剂的设计提供了基础。